Tonix Pharmaceuticals Hol... (TNXP)
NASDAQ: TNXP
· Real-Time Price · USD
39.77
-2.25 (-5.35%)
At close: May 30, 2025, 3:59 PM
39.99
0.54%
After-hours: May 30, 2025, 05:57 PM EDT
-5.35% (1D)
| Bid | 39.78 |
| Market Cap | 291.34M |
| Revenue (ttm) | 10.04M |
| Net Income (ttm) | -115.1M |
| EPS (ttm) | 356.28 |
| PE Ratio (ttm) | 0.11 |
| Forward PE | -8.96 |
| Analyst | Strong Buy |
| Ask | 40.2 |
| Volume | 1,536,126 |
| Avg. Volume (20D) | 1,516,356 |
| Open | 41.72 |
| Previous Close | 42.02 |
| Day's Range | 36.65 - 42.96 |
| 52-Week Range | 6.76 - 544.00 |
| Beta | 1.64 |
About TNXP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TNXP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TNXP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+32.48%
Tonix Pharmaceutical shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
-19.78%
Tonix Pharmaceuticals Holdings shares are trading lower after the company reported mixed Q4 financial results.
2 months ago · seekingalpha.com
Tonix Pharmaceuticals: Potential To Have 'First' New Fibromyalgia Drug In 15 YearsPDUFA date of August 15th of 2025 set to review on whether or not TNX-102 SL should be approved to treat patients with Fibromyalgia. The company announced that the FDA will not require an Advisory Com...
